UroGen Pharma Ltd. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
UroGen Pharma Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • UroGen Pharma Ltd. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.49M, a 56.9% increase year-over-year.
  • UroGen Pharma Ltd. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.4M, a 36.4% increase year-over-year.
  • UroGen Pharma Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $9.34M, a 11.7% decline from 2022.
  • UroGen Pharma Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 54.2% decline from 2021.
  • UroGen Pharma Ltd. annual Share-based Payment Arrangement, Expense for 2021 was $23.1M, a 17.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.34M -$1.24M -11.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $10.6M -$12.5M -54.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $23.1M -$4.91M -17.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $28M -$1.94M -6.48% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $30M -$675K -2.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 $30.6M +$24.3M +386% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $6.3M +$4.33M +220% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $1.97M +$1.52M +338% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $449K Jan 1, 2015 Dec 31, 2015 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.